RT-PCR for tyrosinase-mRNA-positive cells in peripheral blood: Evaluation strategy and correlation with known prognostic markers in 123 melanoma patients

Journal of Investigative Dermatology

Volumn 110, Issue 3, 1998, Pages 263-267

  Farthmann, Birgit ^a   Eberle, Jürgen ^a   Krasagakis, Konstantin ^a   Gstöttner, Martina ^a   Wang, Nanping ^a   Bisson, Susanne ^a   Orfanos, Constantin E ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Metastasis; Polymerase chain reaction; Reverse transcription

Indexed keywords

MONOPHENOL MONOOXYGENASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT LENTIGO; MELANOCYTE; MELANOMA; METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SKIN METASTASIS;

EID: 0031891096     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1998.00131.x     Document Type: Article

References (24)

1. Barnhill RL, Fine JA, Roush GC, Berwick M: Predicting five-year outcome for patients with cutaneous melanoma in a population-based study. Cancer 78:427-432, 1996
2. Battayani Z, Grob JJ, Xerri L, et al: Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma. Arch Dermatol 131:443-447, 1995
3. Breslow A: Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172:902-908, 1970
4. Brossart P, Keilholz U, Willhauck M, Scheibenbogen C, Möhler T: Hematogenous spread of malignant melanoma cells in different stages of disease. J Invest Dermatol 101:887-889, 1993
5. Burchill SA, Bradbury MF, Pittman K, Southgate J, Smith B, Selby P: Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 71:278-281, 1995
6. Carey TE, Takahashi T, Resnick LA, Oettgen HF, Old LJ: Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Natl Acad Sci USA 73:3278-3282, 1976
7. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
8. Clark WH, From L, Bernardino EA: The histologenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 29:705-726, 1969
9. Curry BJ, Smith MJ, Hersey P: Detection and quantitation of melanoma cells in the circulation of patients. Melanoma Res 6:45-54, 1996
10. Eberle J, Garbe C, Wang N, Orfanos CE: Incomplete expression of the tyrosinase gene family (tyrosinase, TRP-1, and TRP-2) in human malignant melanoma cells in vitro. Pigment Cell Res 8:307-313, 1995
11. Ercolani L, Florence B, Denaro M, Alexander H: Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem 30:15335-15341, 1988
12. Garbe C, Orfanos CE: Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society. Pigment Cell Res Suppl. 2:285-294, 1992
13. Hoon DS, Wang Y, Dale PS, et al: Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 13:2109-2116, 1995
14. Johnson PWM, Burchill SA, Selby PJ: The molecular detection of circulating tumour cells. Br J Cancer 72:268-276, 1995
15. Kunter U, Buer J, Probst M, et al: Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. J Natl Cancer Inst 88:590-594, 1996
16. Kwon BS, Jaq AK, Pomerantz SH, Halaban R: Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus. Proc Natl Acad Sci USA 84:7473-7477, 1987
17. Mellado B, Colomer D, Castel T, et al: Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis. J Clin Oncol 14:2091-2097, 1996
18. Morton DL, Davtyan DG, Wanek LA, Foshag LJ, Cochran AJ: Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark's level and Breslow thickness. Cancer 71:3737-3743, 1993
19. Pittman K, Burchill S, Smith B, Southgate J, Joffe J, Gore M, Selby P: Reverse transcriptase-polymerase chain reaction for expression of tyrosinase to identify malignant melanoma cells in peripheral blood. Ann Oncol 7:297-301, 1996
20. Reinhold U, Lüdtke-Handjery HC, Schnautz S, Kreysel HW, Abken H: The analysis of tyrosinase-specific mRNA in blood samples of melanoma patients by RT-PCR is not a useful test for metastatic tumor progression. J Invest Dermatol 108:166-169, 1997
21. Schuchter L, Schultz DJ, Synnestvedt M, et al: A prognostic model for predicting 10-year survival in patients with primary melanoma. Ann Intern Med 125:369-375, 1996
22. Sirott MN, Bajorin DF, Wong GYC: Prognostic factors in patients with metastatic malignant melanoma. Cancer 72:3091-3098, 1993
23. Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair GE: Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338:1227-1229, 1991
24. Thörn M, Adami HO, Ringborg U, Bergström R, Krusemo UB: Long-term survival in malignant melanoma with special reference to age and sex as prognostic factors. J Natl Cancer Inst 79:969-974, 1987